PRDX1 and esophageal squamous cell carcinoma: In order to further characterize and validate the identified tumor-associated protein Prdx1, recombinant Prdx1 protein was subsequently used as a target antigen to screen the anti-Prdx1 autoantibody in sera from patients with ESCC and normal individuals by ELISA and western blotting.